跳至主要内容
临床试验/DRKS00026242
DRKS00026242尚未招募4 期

Evaluation of the effect of immersive virtual reality-based upper extremity rehabilitation in hemiparesis and hemiplegia compared to standard therapeutic care: A randomized controlled trial.

ReHub GmbH0 个研究点目标入组 112 人开始时间: 2022年2月18日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 70 Years(—)
性别
All

入选标准

  • One of the following diagnoses:
  • - ICD10 G81.0: Flaccid hemiparesis and hemiplegia.
  • - ICD10 G81.1: Spastic hemiparesis and hemiplegia
  • - ICD10 G81.9: Hemiparesis and hemiplegia, unspecified
  • - First cerebrovascular brain injury (stroke) 3 to 12 months ago
  • - Age range: 40-70 years
  • - Ability to sit without support for more than 10 seconds
  • - Ability to follow simple verbal instructions
  • - No previous experience with Rehago or any other VR therapy app
  • - Sufficient knowledge of German to operate the app
  • - Explicit consent to participate in the study

排除标准

  • - Symptomatic neurologic pre-condition, especially chronic progressive or recurrent like Multiple sclerosis or severe Muscle diseases
  • - Heart failure
  • - debilitating chronic dizziness
  • - Impaired vision
  • - Severe intellectual disability or dementia
  • - Mental illness with delusional perceptual processing
  • - Photosensitive Epilepsy
  • - Bilateral pareses of upper extremity
  • - Severe Aphasia that prevents the use of the therapeutic device

研究者

发起方
ReHub GmbH

相似试验